Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: Insights from the Heart of Soweto Study

Heart

Volumn 96, Issue 23, 2010, Pages 1878-1882

  Sliwa, Karen ^a,b   Carrington, Melinda Jane ^b,c   Klug, Eric ^d   Opie, Lionel ^a   Lee, Geraldine ^b   Ball, Jocasta ^c   Stewart, Simon ^b,c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^d UNIVERSITY OF THE WITWATERSRAND   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATENOLOL; CARVEDILOL; DIGOXIN; ENALAPRIL; FUROSEMIDE; NIFEDIPINE; PERINDOPRIL; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; WARFARIN;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CORONARY ARTERY DISEASE; DISEASE PREDISPOSITION; DISEASE REGISTRY; DIZZINESS; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART FAILURE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART PALPITATION; HEART RATE; HEART RIGHT BUNDLE BRANCH BLOCK; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; NEGRO; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL METHOD; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RHEUMATIC HEART DISEASE; SCORING SYSTEM; SEX DIFFERENCE; SMOKING; SYSTOLIC DYSFUNCTION; THROMBOEMBOLISM; TRICUSPID VALVE REGURGITATION; URBAN AREA; VALVULAR HEART DISEASE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; SEX DISTRIBUTION; SOUTH AFRICA; THROMBOEMBOLISM; URBAN HEALTH; YOUNG ADULT;

EID: 78649911847     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.206938     Document Type: Article

References (30)

1. Stewart S, Hart CL, Hole DJ, et al. Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart 2001;86:516-21.
2. Steinberg JS. Atrial fibrillation: an emerging epidemic? Heart 2004;90:239-40.
3. Stewart S, MacIntyre K, MacLeod ME, et al. Trends in hospital activity, morbidity and case fatality related to atrial fibrillation in Scotland, 1986-1996. Eur Heart J 2001;22:693-701.
4. Murphy NF, Simpson CR, Jhund PS, et al. A national survey of the prevalence, incidence, primary care burden and treatment of atrial fibrillation in Scotland. Heart 2007;93:606-12.
5. Benjamin EJ, Levy D, Vizari SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham heart study. JAMA 1994;271:840-4.
6. Borzecki AM, Bridgers DK, Liebschutz JM, et al. Racial differences in the prevalence of atrial fibrillation among males. J Natl Med Assoc 2008;100:237-45.
7. Meschia JF, Merrill P, Soliman EZ, et al. Racial disparities in awareness and treatment of atrial fibrillation: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Stroke 2010;41:581-7.
8. Sliwa K, Wilkinson D, Hansen C, et al. Spectrum of heart disease and risk factors in a black urban population in South Africa (the Heart of Soweto Study): a cohort study. Lancet 2008;371:915-22.
9. Sliwa K, Carrington M, Mayosi BM, et al. Incidence and characteristics of newly diagnosed rheumatic heart disease in Urban African adults: insights from the Heart of Soweto Study. Eur Heart J 2010;31:719-27.
10. Tibazarwa K, Ntyintyane L, Sliwa K, et al. A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study "Heart Awareness Days". Int J Cardiol 2009;132:233-9.
11. Prineas R, Crow R, Blackburn H. The Minnesota Code Manual of Electrocardiographic Findings: Standards and Procedures for Measurement and Classification. Boston, Massachusetts: John Wright, 1982.
12. Sahn DJ, DeMaria A, Kisslo J, et al. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 1978;58:1072-83.
13. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442.
14. Lainscak M, Cleland JG, Lenzen MJ, et al. International variations in the treatment and co-morbidity of left ventricular systolic dysfunction: data from the EuroHeart Failure Survey. Eur J Heart Fail 2007;9:292-9.
15. Lip GYH. The balance between stroke prevention and bleeding risk in atrial fibrillation: a delicate balance revisited. Stroke 2008;39:1406-8.
16. Statistical Release P0302-Mid-year population estimates. Statistics South Africa 2010.
17. Ntep-Gweth M, Zimmermann M, Meiltz A, et al. Atrial fibrillation in Africa: clinical characteristics, prognosis, and adherence to guidelines in Cameroon. Europace 2010;12:482-7.
18. Mamas MA, Caldwell JC, Chacko S, et al. A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure. Eur J Heart Fail 2009;11:676-83.
19. Stewart S, Wilkinson D, Hansen C, et al. Predominance of heart failure in the Heart of Soweto Study cohort: emerging challenges for urban African communities. Circulation 2008;118:2360-7.
20. Rutten FH, Cramer MJ, Lammers JW, et al. Heart failure and chronic obstructive pulmonary disease: an ignored combination? Eur J Heart Fail 2006;8:706-11.
21. Henriksson KM, Farahmand B, Johansson S, et al. Survival after stroke - the impact of CHADS2 score and atrial fibrillation. Int J Cardiol 2010;141:18-23.
22. Huddle K, Dubb A. Baragwanath Hospital: 50 years - A Medical Miscellany. South Africa: Department of Medicine, Baragwanath Hospital, 1994.
23. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus Warfarin in patients with atrial fibrillation. N Engl J Med 2009;361:1139-51.
24. Connolly SJ, Pogue J, Hart RG, et al; ACTIVE Investigators. Effect of clopidogrel added to aspirin in patients with atrial fibrillation. N Engl J Med 2009;360:2066-78.
25. Van Gelder IC, Groenveld HF, Crijns HJ, et al. Lenient versus strict rate control in patients with atrial fibrillation. N Engl J Med 2010;362:1363-73.
26. Langerveld J, Ernst JMPG, van Hemel NM, et al. Indication and timing of percutaneous mitral balloon valvotomy and the role of atrial fibrillation. Neth Heart J 2005;13:4-10.
27. Hohnloser SH, Crijns HJGM, van Eickels M, et al. Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 2009;360:668-78.
28. Long MJ, Jiang CQ, Lam TH, et al. Atrial fibrillation and obesity among older Chinese: the Guangzhou Biobank Cohort Study. Int J Cardiol 2009 Nov 25 Published online first. PMID: 19944468.
29. Rosengren A, Hauptman PJ, Lappas G, et al. Big men and atrial fibrillation: effects of body size and weight gain on risk of atrial fibrillation in men. Eur Heart J 2009;30:1113-20.
30. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453-7.